PRESS RELEASE published on 03/05/2026 at 09:16, 17 days 13 hours ago Press Release: Sanofi’s Board of Directors proposes the appointment of Christel Heydemann as an independent director Sanofi's Board of Directors proposes appointment of Christel Heydemann as independent director, renewing mandates, and thanking Patrick Kron. Heydemann brings expertise in industrial and digital transformation, strengthening governance diversity Board Of Directors Governance Diversity Sanofi Christel Heydemann
PRESS RELEASE published on 03/05/2026 at 09:16, 17 days 13 hours ago Communiqué de presse : Le Conseil d’administration de Sanofi propose la nomination de Christel Heydemann en qualité d’administratrice indépendante Le Conseil d'administration de Sanofi propose la nomination de Christel Heydemann en tant qu'administratrice indépendante lors de l'Assemblée générale des actionnaires. Restructuration de la gouvernance chez Sanofi Gouvernance Conseil D'administration Nomination Sanofi Christel Heydemann
BRIEF published on 03/04/2026 at 18:35, 18 days 4 hours ago Sanofi submits an amendment to the 2025 Universal Registration Document Financial Markets Authority Financial Report Transparency Amendment Sanofi
BRIEF published on 03/04/2026 at 18:35, 18 days 4 hours ago Sanofi dépose un amendement au Document d'Enregistrement Universel 2025 Autorité Des Marchés Financiers Transparence Rapport Financier Sanofi Amendement
BRIEF published on 03/04/2026 at 18:35, 18 days 4 hours ago Sanofi Files Amendment to Annual Financial Report with French Regulator AMF Corporate Governance Annual Financial Report Document D’enregistrement Universel Sanofi
BRIEF published on 03/04/2026 at 18:35, 18 days 4 hours ago Sanofi dépose une modification de son rapport financier annuel auprès de l'autorité de régulation française. AMF Gouvernance D'Entreprise Rapport Financier Annuel Document D'Enregistrement Universel Sanofi
PRESS RELEASE published on 03/04/2026 at 18:30, 18 days 4 hours ago Communiqué de presse : Dépôt d’un amendement au Document d’Enregistrement Universel 2025, contenant le Rapport Financier Annuel Sanofi dépose un amendement au Document d’Enregistrement Universel 2025 contenant le Rapport Financier Annuel auprès de l’AMF en France AMF Rapport Financier Annuel Document D’enregistrement Universel Sanofi Amendement
PRESS RELEASE published on 03/04/2026 at 18:30, 18 days 4 hours ago Press Release: Filing of an amendment to the French “Document d’Enregistrement Universel” containing the Annual Financial Report Sanofi files amendment to French 'Document d’Enregistrement Universel' with annual financial report, including governance updates. Available on Sanofi and AMF websites AMF Financial Report Amendment Sanofi Governance Updates
BRIEF published on 02/27/2026 at 13:08, 23 days 9 hours ago Sanofi and Regeneron’s Dupixent Recommended for EU Approval in Treating Pediatric CSU Sanofi Dupixent CSU Regeneron EMA Approval
BRIEF published on 02/27/2026 at 13:08, 23 days 9 hours ago Dupixent de Sanofi et Regeneron recommandé pour une autorisation de mise sur le marché dans l'UE pour le traitement de l'urticaire chronique spontanée chez l'enfant Sanofi Dupixent CSU Regeneron Approbation De L'EMA
Published on 03/20/2026 at 13:30, 2 days 9 hours ago Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/20/2026 at 12:30, 2 days 10 hours ago CANEX Metals Announces the Numbers of Gold Basin Shares Taken up by Canex Metals
Published on 03/22/2026 at 12:23, 10 hours 27 minutes ago Borussia Dortmund and Sebastian Kehl are ending their collaboration with immediate effect
Published on 03/20/2026 at 22:45, 2 days ago Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 2 days 1 hour ago Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications
Published on 03/20/2026 at 21:05, 2 days 1 hour ago Nebius Group announces closing of private offering of convertible senior notes, with aggregate gross proceeds of approximately $4.3 billion
Published on 03/20/2026 at 19:00, 2 days 3 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 3 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 4 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 4 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA